Global Bioinformatics Market– Trends and Forecast to 2024

Global Bioinformatics Market By Industry, By Product Type (Sequencing Platforms, Knowledge Management Tools, Bioinformatics Software), By Application, By Services (Data Analysis, Sequencing, Database integration, Others), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) – Trend and Forecast to 2024

Dallas, TX, March 15, 2017 --(PR.com)-- Global bioinformatics market is expected to reach USD 22.78 billion by 2024 from USD 6.54 billion in 2016, at a CAGR of 16.8% in the forecast period 2017 to 2024.

The global bioinformatics market is segmented based on industry, product type, service and application.

Based on industry, the bioinformatics market is segmented into molecular medicine, drug development, clinical diagnostics, agriculture, forensic, animal, academics and research, environmental and gene therapy.

Based on product type, the bioinformatics market is segmented into sequencing platforms, knowledge management tools and bioinformatics software.

Based on applications, the bioinformatics market is segmented into preventive medicine, molecular medicine, genomics, drug development, transcriptomics and, other biotechnological applications.

Based on services, the bioinformatics market is segmented into data analysis, sequencing, data integration among others.

Request for sample pages: https://databridgemarketresearch.com/reports/global-bioinformatics-market/

Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The geographical regions are further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many others. U.S. is expected to dominate the market due to large investments in public and private research for drug developments and gene therapy.

Read more: https://databridgemarketresearch.com/global-bioinformatics-market-expected-reach-usd-16-7-billion-2022/

The major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. Some of the examples for these strategies are: In March 2017, Agilent Technologies Inc. introduced its first comparative genomic hybridization (CGH) assay which will be used for diagnostic purposes: the GenetiSureDx Postnatal Assay. This will help the clinical geneticists to detect genetic anomalies early with more accuracy as compared to than traditional methods.

Some of the major players operating in this market are Illumina, Inc., DNAnexus, Inc., Qiagen, Thermo Fisher Scientific, Inc., Agilent Technologies, DassaultSystemes, Geneva Bioinformatics (Genebio) SA, Integromics S.L., Perkinelmer, Inc., Applied Biological Materials (ABM) among others.

About Data Bridge Market Research:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Info:
Ravi Dubey
Office Number 317, Amanora Chambers,
Magarpatta Road, Hadapsar
Pune – 411028
Maharashtra, India
Toll Free: +1-888-387-2818
Mail: sales@databridgemarketresearch.com
LinkedIn: https://www.linkedin.com/company/data-bridge-market research?trk=nav_account_sub_nav_company_admin
Contact
Data Bridge Market Research
Ravi Dubey
+1-888-387-2818
http://databridgemarketresearch.com/
Visit Data Bridge Blog @ http://databridgemarketresearch.com/blog/
ContactContact
Categories